Are Analysts Too Bullish On NKGen Biotech Inc (NKGN)

NKGen Biotech Inc (NASDAQ:NKGN) currently has a daily average trading volume of 1.21M but it saw 3827527 shares traded in last market. With a market cap of 11.99M USD, the company’s current market price of $0.34 came rising about 7.83 while comparing to the previous closing price of $0.31. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.06 and as low as $0.20. In the recent trading on the day, stock has struck highest price mark of $0.32 while lowest mark touched by it was $0.439.

Taking a look at 20-day trading activity of NKGen Biotech Inc (NKGN) gives us an average price of $0.2884, while its current price level is -91.69% below from 52-week high level whereas it is 66.58% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3603 while that of 200 days or SMA-200 reads an average of $1.0648. A closer look into the stock’s movement over the week reveals that its volatility is standing at 19.39% during that period while stretching the period over a month that decreases to 14.32%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 52.27 which implies that the stock is in neutral territory.

Over the week, NKGN’s stock price is moving 21.80% up while it is -12.29% when we observe its performance for the past one month. Year-to-date it is -87.73% down and over the past year, the stock is showing a downside performance of -87.83%.

The company is expected to be releasing its next quarterly report in December, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.

Currently, NKGen Biotech Inc’s total number of outstanding shares is 21.89M with 42.32% of that held by the insiders while 12.20% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -118.66%. Stock’s beta reads 0.57. Its return on asset (ROA) is -196.21% on average.